Suppr超能文献

金属硫蛋白2A基因多态性与癌症风险关联的定量评估。

Quantitative assessment of the association of polymorphisms in the metallothionein 2A gene with cancer risk.

作者信息

Wang Jianguo, Huang Pinghua, Zhao Wei, Ren Wei, Ai Ling, Wu Liping

机构信息

Department of Prenatal Diagnostic, Jiaxing Maternity and Children Health Care Hospital, Jiaxing University, Jiaxing, Zhejiang, China.

出版信息

J Int Med Res. 2020 Aug;48(8):300060520947937. doi: 10.1177/0300060520947937.

Abstract

OBJECTIVE

The aim of the study was to quantitatively assess the association of metallothionein 2A () polymorphisms rs28366003 and rs1610216 with cancer risk.

METHODS

Crude odd ratios (OR) with 95% confidence intervals (CI) were used to estimate associations of the polymorphisms with cancer risk.

RESULTS

Six eligible case-control studies with 1899 cases and 2437 controls focused on rs28366003, and three of those six studies, with 548 cases and 926 controls, additionally focused on rs1610216. Pooled analysis showed that rs28366003 and rs1610216 were associated with cancer risk: (AG + GG) vs. AA, OR = 2.67; GG vs. (AG + AA), OR = 5.97; GG vs. AA, OR = 6.80; AG vs. AA, OR = 2.46; G vs. A, OR = 2.67 for rs28366003; and CC vs. (TC+TT), OR = 2.51; CC vs. TT, OR = 2.42 for rs1610216. Subgroup analysis based on ethnicity showed a significant association of rs28366003 with cancer risk in Asian and Caucasian populations. However, a significant association of rs1610216 with cancer risk was found only in the Asian population.

CONCLUSION

rs28366003 and rs1610216 polymorphisms were associated with cancer risk and might serve as genetic biomarkers for predicting cancer risk. However, larger studies are needed to confirm these findings.

摘要

目的

本研究旨在定量评估金属硫蛋白2A(MT2A)基因多态性rs28366003和rs1610216与癌症风险的关联。

方法

采用粗比值比(OR)及95%置信区间(CI)来估计多态性与癌症风险的关联。

结果

六项符合条件的病例对照研究(共1899例病例和2437例对照)聚焦于rs28366003,其中三项研究(共548例病例和926例对照)还额外聚焦于rs1610216。汇总分析显示,rs28366003和rs1610216与癌症风险相关:对于rs28366003,(AG + GG)与AA相比,OR = 2.67;GG与(AG + AA)相比,OR = 5.97;GG与AA相比,OR = 6.80;AG与AA相比,OR = 2.46;G与A相比,OR = 2.67;对于rs1610216,CC与(TC + TT)相比,OR = 2.51;CC与TT相比,OR = 2.42。基于种族的亚组分析显示,rs28366003在亚洲和白种人群中与癌症风险存在显著关联。然而,仅在亚洲人群中发现rs1610216与癌症风险存在显著关联。

结论

rs28366003和rs1610216多态性与癌症风险相关,可能作为预测癌症风险的遗传生物标志物。然而,需要更大规模的研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf0/7436784/9161ee6d6479/10.1177_0300060520947937-fig1.jpg

相似文献

1
Quantitative assessment of the association of polymorphisms in the metallothionein 2A gene with cancer risk.
J Int Med Res. 2020 Aug;48(8):300060520947937. doi: 10.1177/0300060520947937.
2
METALLOTHIONEIN-2A (RS1610216&RS28366003) GENE POLYMORPHISMS AND THE RISK OF STOMACH ADENOCARCINOMA.
Arq Gastroenterol. 2019 Oct-Dec;56(4):367-371. doi: 10.1590/S0004-2803.201900000-69.
3
Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.
Cancer Genet. 2012 Sep;205(9):432-5. doi: 10.1016/j.cancergen.2012.05.005. Epub 2012 Jul 21.
4
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.
Clin Exp Med. 2014 Feb;14(1):107-13. doi: 10.1007/s10238-012-0215-4. Epub 2012 Oct 6.
6
Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.
Med Oncol. 2014 Jul;31(7):75. doi: 10.1007/s12032-014-0075-8. Epub 2014 Jun 22.
7
Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
Ophthalmic Genet. 2017 Sep-Oct;38(5):451-458. doi: 10.1080/13816810.2017.1288825. Epub 2017 Mar 1.
8
Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans.
Arh Hig Rada Toksikol. 2020 Mar 1;71(1):27-47. doi: 10.2478/aiht-2020-71-3349.
9
Association between lncRNA H19 polymorphisms and cancer susceptibility based on a meta-analysis from 25 studies.
Gene. 2020 Mar 1;729:144317. doi: 10.1016/j.gene.2019.144317. Epub 2019 Dec 26.
10
The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies.
Medicine (Baltimore). 2017 Aug;96(32):e7467. doi: 10.1097/MD.0000000000007467.

引用本文的文献

2
and Genes Expression in Gastritis and Gastric Cancer Patients with Infection.
Can J Gastroenterol Hepatol. 2022 Aug 25;2022:8699408. doi: 10.1155/2022/8699408. eCollection 2022.

本文引用的文献

1
Meta-analysis of the association between Glu346Lys polymorphism and cancer risk.
J Int Med Res. 2024 Oct;52(10):300060519895667. doi: 10.1177/0300060519895667. Epub 2019 Dec 31.
2
METALLOTHIONEIN-2A (RS1610216&RS28366003) GENE POLYMORPHISMS AND THE RISK OF STOMACH ADENOCARCINOMA.
Arq Gastroenterol. 2019 Oct-Dec;56(4):367-371. doi: 10.1590/S0004-2803.201900000-69.
3
Association between A240T polymorphism and cancer risk: a meta-analysis.
J Int Med Res. 2019 Dec;47(12):5917-5925. doi: 10.1177/0300060519882559. Epub 2019 Nov 6.
4
Negatively Modulates in Tumor Formation of Clear Cell Renal Cell Carcinoma.
DNA Cell Biol. 2019 Jul;38(7):700-707. doi: 10.1089/dna.2018.4549. Epub 2019 May 15.
8
Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.
Med Oncol. 2014 Jul;31(7):75. doi: 10.1007/s12032-014-0075-8. Epub 2014 Jun 22.
9
Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.
DNA Cell Biol. 2014 May;33(5):320-7. doi: 10.1089/dna.2013.2273. Epub 2014 Feb 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验